Surgery Partners, Inc.
General ticker "SGRY" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $2.0B (TTM average)
Surgery Partners, Inc. does not follow the US Stock Market performance with the rate: -8.8%.
Estimated limits based on current volatility of 2.3%: low 13.76$, high 14.41$
Factors to consider:
- Total employees count: 16000 (+6.7%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insurer payment reductions, Failure to grow physician relationships, Regulatory and compliance, Insufficient capital, Supply chain disruptions
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.48$, 19.40$]
- 2026-12-31 to 2027-12-31 estimated range: [10.26$, 18.77$]
Financial Metrics affecting the SGRY estimates:
- Positive: with PPE of 34.0 at the end of fiscal year the price was neutral
- Positive: 11.29 < Operating profit margin, % of 11.77
- Negative: 0 < Inventory ratio change, % of 0.08
- Positive: 11.37 < Operating cash flow per share per price, % of 13.77
- Negative: Investing cash flow per share per price, % of -12.38 <= -11.23
- Negative: Industry operating profit margin (median), % of -0.34 <= 0.59
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.56
Short-term SGRY quotes
Long-term SGRY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,743.30MM | $3,114.30MM | $3,308.70MM |
| Operating Expenses | $2,415.30MM | $2,765.50MM | $2,919.20MM |
| Operating Income | $328.00MM | $348.80MM | $389.50MM |
| Non-Operating Income | $-193.00MM | $-201.70MM | $-272.60MM |
| Interest Expense | $193.00MM | $201.70MM | $272.60MM |
| Income(Loss) | $135.00MM | $147.10MM | $116.90MM |
| Taxes | $0.30MM | $134.60MM | $18.00MM |
| Net Income(Loss)* | $-11.90MM | $-168.10MM | $-77.90MM |
| Stockholders Equity | $1,987.20MM | $1,789.70MM | $1,712.90MM |
| Inventory | $75.20MM | $88.40MM | $96.60MM |
| Assets | $6,876.70MM | $7,890.00MM | $8,242.00MM |
| Operating Cash Flow | $293.80MM | $300.10MM | $274.30MM |
| Capital expenditure | $88.80MM | $90.40MM | $78.70MM |
| Investing Cash Flow | $-225.60MM | $-488.50MM | $-246.60MM |
| Financing Cash Flow | $-155.20MM | $262.00MM | $-57.30MM |
| Earnings Per Share** | $-0.09 | $-1.33 | $-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.